Kendley announced that the company previously disclosed that its wholly-owned subsidiary Guangdong Medical Devices Group plans to transfer 7% of Guangxi Ouwen's shares to Ouwen Holding Group, New Era, and New Resonance for 52.5 million yuan, respectively. As of the disclosure date of the announcement, Guangdong Medical Devices Group has received all equity transfers and completed the industrial and commercial change registration procedures for related equity changes; after the transaction was completed, the company indirectly held 44% of Guangxi Ouwen's shares, and Guangxi Ouwen was no longer included in the scope of the company's consolidated statements.

Kendley announced that the company previously disclosed that its wholly-owned subsidiary Guangdong Medical Devices Group plans to transfer 7% of Guangxi Ouwen's shares to Ouwen Holding Group, New Era, and New Resonance for 52.5 million yuan, respectively. As of the disclosure date of the announcement, Guangdong Medical Devices Group has received all equity transfers and completed the industrial and commercial change registration procedures for related equity changes; after the transaction was completed, the company indirectly held 44% of Guangxi Ouwen's shares, and Guangxi Ouwen was no longer included in the scope of the company's consolidated statements.